Antimicrobial resistance at the highest political level: the beginning of the end or the end of the beginning?

By Bojana Beovic Antimicrobial resistance was discussed at the United Nations General Assembly (#UNGA) held on September 21, 2016. For the first time the leaders of 193 Member States agreed for a … Continue Reading →

EU report on the implementation of the (2001) recommendation on the prudent use of antibiotics

The European Commission relased a report (download report here) on the implementation of the Council recommendation of 15 November 2001 on the prudent use of antimicrobial agents in human medicine. This … Continue Reading →

Is your Infectious Disease or Clinical Micro Service Understaffed? Have a look

By Bojana Beovic Infectious diseases and clinical microbiology specialties have undergone extreme changes in its scope in the last decades. Starting with HIV epidemics, these changes are far from and … Continue Reading →

Ten key points for the appropriate use of antibiotics in hospitalized patients

While celebrating the top-performing year among the different study groups of the ESCMID at the last ECCMID, the ESGAP executive committee was also receiving and discussing proposals for international collaborations … Continue Reading →

ESGAP and SPILF survey on duration of antimicrobial therapy is open

  ESGAP (the ESCMID Study Group for Antibiotic Policies) and SPILF (the French ID society) are launching the AB-Duration survey. Duration of antibiotic therapy is a not completely solved issue for many … Continue Reading →

Do your patients know your local antibiotic resistance rates?

By Oliver Dyar Public Health England have recently made local data publicly available on five important topics: antimicrobial resistance antibiotic prescribing healthcare associated infections infection prevention and control and antibiotic … Continue Reading →

Have your Say on the Future EU Guidelines on Prudent Use of Antimicrobials in Human Medicine

After the publication of the EU Guidelines for prudent use of antimicrobials in veterinarian medicine in 2015 (see here), commissioned by the European Commission, ECDC received a request from DG-SANTE … Continue Reading →

Legal responsibility associated w/ antibiotic prescribing and advising. Deadline: Sept 1st

Are you a senior Infectious Diseases physician or Clinical Microbiologist ? Would you like to help us learn about legal responsibility associated with antibiotic prescribing and advising?   If Yes, then you can!!! … Continue Reading →

Using antibiotics responsibly: are we there yet?

By Oliver Dyar A perspective piece on responsible antibiotic use has just been published in Future Microbiology, and the authors include several ESGAP members.   In the article we present … Continue Reading →

One great example of “When less is more…”

By Leonardo Pagani (ESGAP EC member) About 60% of antibiotics prescribed in primary care are for RTIs, such as common colds, sore throat, cough, acute bronchitis, otitis media and sinusitis. … Continue Reading →